United States · FDA National Drug Code directory
Gadavist
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50419-325_8ff60f35-0672-462a-b5d8-c2fd9e2a4566
- Product NDC
- 50419-325
- Form
- INJECTION
- Composition / generic term
- gadobutrol
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20110314
- Source listing expiry
- 20271231
Source-listed ingredients
- GADOBUTROL — 604.72 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 CARTON in 1 BOX (50419-325-18) / 5 BOTTLE, GLASS in 1 CARTON / 30 mL in 1 BOTTLE, GLASS · 50419-325-18
- 10 BOTTLE, GLASS in 1 BOX (50419-325-19) / 65 mL in 1 BOTTLE, GLASS · 50419-325-19
- 30 mL in 1 BOTTLE, GLASS (50419-325-73) · 50419-325-73
- 65 mL in 1 BOTTLE, GLASS (50419-325-74) · 50419-325-74
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →